Buscar por Materia Ovarian cancer
Mostrando resultados 1 a 14 de 14
| Vista previa | Fecha de publicación | Fecha de Creación | Título |
 | 2006 | - | Topoisomerase 1A, HER,2neu and Ki67 expression in paired primary
and relapse ovarian cancer tissue samples |
 | 2006 | - | Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors |
 | 2008 | - | Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor |
 | 2009 | - | Prognostic significance of tumour vascularisation on survival of patients with advanced ovarian carcinoma |
 | 2009 | - | Claudins as diagnostic and prognostic markers in gynecological cancer |
 | 2012 | - | Ovarian cancer: insights into genetics and pathogeny |
 | 2013 | - | Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX™ detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8 |
 | 2015 | - | Tumor heterogeneity has important consequences
for personalized medicine in ovarian cancer |
 | 2017 | - | Principales complicaciones asociadas a la administración de quimioterapia intraperitoneal y endovenosa en pacientes con cáncer de ovario |
 | 2018 | - | Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals |
 | 22-nov-2018 | 5-oct-2018 | La endometriosis atípica como lesión precursora del cáncer de ovario asociado a endometriosis un estudio prospectivo |
 | 2022 | - | AADAC promotes therapeutic activity of cisplatin and imatinib against ovarian cancer cells |
 | 2023 | - | Up-regulation of oxidized low-density lipoprotein receptor 1 correlates with decreased miR-106b-5p, miR-93-5p, miR-3129-5p, miR-199b-3p, and miR-4465, higher recurrence rate, and poor prognosis in ovarian cancer
J. Liu, Y. Zeng and L. Zheng |
 | 2023 | - | MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer |
